miR‐10b*, a master inhibitor of the cell cycle, is down‐regulated in human breast tumours-Reference-Cited by-同舟云学术

miR‐10b*, a master inhibitor of the cell cycle, is down‐regulated in human breast tumours

Published:2012-11 Issue:11 Volume:4 Page:1214-1229
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Biagioni Francesca¹,Bossel Ben‐Moshe Noa²,Fontemaggi Giulia¹,Canu Valeria¹,Mori Federica³,Antoniani Barbara⁴,Di Benedetto Anna⁴,Santoro Raffaela³,Germoni Sabrina⁵,De Angelis Fernanda¹,Cambria Anna⁶,Avraham Roi⁷,Grasso Giuseppe⁶,Strano Sabrina³,Muti Paola⁸,Mottolese Marcella⁴,Yarden Yosef⁹,Domany Eytan²,Blandino Giovanni¹

Affiliation:

1. Translational Oncogenomic Unit, Regina Elena National Cancer Institute, Rome, Italy

2. Department of Physics of Complex Systems, Weizmann Institute of Science, Rehovot, Israel

3. Molecular Chemoprevention Group, Regina Elena National Cancer Institute, Rome, Italy

4. Department of Pathology, Regina Elena National Cancer Institute, Rome, Italy

5. SAFU Department, Regina Elena National Cancer Institute, Rome, Italy

6. Department of Oncology, Division of Pathology, S. Vincenzo Hospital, Taormina, Italy

7. Broad Institute of MIT and Harvard, Cambridge, MA, USA

8. Department of Oncology, Juravinski Cancer Center McMaster University Hamilton, Ontario, Canada

9. Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/emmm.201201483

Reference50 articles.

1. Faster cyclic loess: normalizing RNA arrays via linear models

2. [19] Gene Expression Omnibus: Microarray Data Storage, Submission, Retrieval, and Analysis

3. MicroRNAs

4. Functional relevance of miRNA* sequences in human disease

5. MicroRNA Expression Patterns to Differentiate Pancreatic Adenocarcinoma From Normal Pancreas and Chronic Pancreatitis

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BUB1 induces AKT/mTOR pathway activity to promote EMT induction in human small cell lung cancer;Scientific Reports;2024-09-04

2. MiR-338–5p, a novel metastasis-related miRNA, inhibits triple-negative breast cancer progression by targeting the ETS1/NOTCH1 axis;Heliyon;2024-08

3. Functional combination of resveratrol and tamoxifen to overcome tamoxifen‐resistance in breast cancer cells;Archiv der Pharmazie;2024-06-29

4. Over-expression of mir-181a-3p in serum of breast cancer patients as diagnostic biomarker;Molecular Biology Reports;2024-02-27

5. Crosstalk between miRNAs and DNA Methylation in Cancer;Genes;2023-05-12